2023 Q3 Form 10-Q Financial Statement

#000106660523000068 Filed on July 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $267.9M $273.8M
YoY Change 3.73% -9.08%
Cost Of Revenue $30.68M $27.86M
YoY Change 46.89% 40.62%
Gross Profit $237.2M $245.9M
YoY Change -0.07% -12.58%
Gross Profit Margin 88.55% 89.82%
Selling, General & Admin $204.8M $219.4M
YoY Change 0.56% -9.66%
% of Gross Profit 86.33% 89.23%
Research & Development $5.560M $5.658M
YoY Change 2.96% 24.49%
% of Gross Profit 2.34% 2.3%
Depreciation & Amortization $2.400M $4.819M
YoY Change 33.33% 167.72%
% of Gross Profit 1.01% 1.96%
Operating Expenses $5.560M $225.1M
YoY Change -97.58% -15.77%
Operating Profit $22.14M $20.83M
YoY Change -21.84% -38.49%
Interest Expense $2.500M $1.913M
YoY Change 99.2% 539.8%
% of Operating Profit 11.29% 9.18%
Other Income/Expense, Net $1.856M $1.377M
YoY Change 53.14% 28.33%
Pretax Income $24.00M $16.88M
YoY Change -18.64% -51.65%
Income Tax $9.000M $7.893M
% Of Pretax Income 37.5% 46.77%
Net Earnings $14.99M $8.982M
YoY Change -28.04% -62.81%
Net Earnings / Revenue 5.59% 3.28%
Basic Earnings Per Share $0.75 $0.45
Diluted Earnings Per Share $0.73 $0.44
COMMON SHARES
Basic Shares Outstanding 20.01M shares 20.03M shares
Diluted Shares Outstanding 20.55M shares 20.64M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $334.0M $239.0M
YoY Change -26.75% -29.0%
Cash & Equivalents $286.4M $217.8M
Short-Term Investments $47.56M $21.24M
Other Short-Term Assets $50.61M $41.44M
YoY Change 21.73% -10.52%
Inventory
Prepaid Expenses
Receivables $189.4M $234.5M
Other Receivables $10.80M $8.397M
Total Short-Term Assets $613.2M $523.3M
YoY Change -14.85% -16.67%
LONG-TERM ASSETS
Property, Plant & Equipment $34.03M $103.0M
YoY Change 16.09% 277.45%
Goodwill $198.2M $198.6M
YoY Change 43.58% 43.41%
Intangibles
YoY Change
Long-Term Investments $43.20M $44.36M
YoY Change 36.16% 31.4%
Other Assets $19.53M $68.20M
YoY Change -25.97% 159.35%
Total Long-Term Assets $428.1M $441.1M
YoY Change 21.22% 24.6%
TOTAL ASSETS
Total Short-Term Assets $613.2M $523.3M
Total Long-Term Assets $428.1M $441.1M
Total Assets $1.041B $964.5M
YoY Change -2.98% -1.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.97M $15.48M
YoY Change 9.96% -5.79%
Accrued Expenses $285.6M $215.1M
YoY Change -27.38% -29.5%
Deferred Revenue $41.50M $44.10M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $392.0M $318.8M
YoY Change -24.42% -26.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.99M $209.7M
YoY Change 864.35% 4272.02%
Total Long-Term Liabilities $210.1M $209.7M
YoY Change 23.52% 16.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $392.0M $318.8M
Total Long-Term Liabilities $210.1M $209.7M
Total Liabilities $602.1M $536.1M
YoY Change -12.58% -12.62%
SHAREHOLDERS EQUITY
Retained Earnings $198.4M $186.5M
YoY Change 27.75% 35.59%
Common Stock $248.7M $246.4M
YoY Change 2.84% 3.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $439.1M $428.3M
YoY Change
Total Liabilities & Shareholders Equity $1.041B $964.5M
YoY Change -2.98% -1.79%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $14.99M $8.982M
YoY Change -28.04% -62.81%
Depreciation, Depletion And Amortization $2.400M $4.819M
YoY Change 33.33% 167.72%
Cash From Operating Activities $109.5M $46.94M
YoY Change -20.92% -43.23%
INVESTING ACTIVITIES
Capital Expenditures $2.800M $3.006M
YoY Change -171.07% -223.6%
Acquisitions
YoY Change
Other Investing Activities -$28.40M -$27.20M
YoY Change -84.27% 22566.67%
Cash From Investing Activities -$31.20M -$30.21M
YoY Change -83.09% 1083.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.200M -4.026M
YoY Change 66.67% 29.7%
NET CHANGE
Cash From Operating Activities 109.5M 46.94M
Cash From Investing Activities -31.20M -30.21M
Cash From Financing Activities -5.200M -4.026M
Net Change In Cash 73.10M 12.71M
YoY Change -248.85% -83.5%
FREE CASH FLOW
Cash From Operating Activities $109.5M $46.94M
Capital Expenditures $2.800M $3.006M
Free Cash Flow $106.7M $43.93M
YoY Change -25.07% -48.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
179000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20037959 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19866287 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20007771 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19861207 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
200000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
199000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
30188 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5080 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
819000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
191000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
246226000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
246630000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
186531000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
168197000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3821000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4189000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
428317000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
410646000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
964455000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1175638000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271225000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
298701000 usd
CY2023Q2 us-gaap Revenues
Revenues
273777000 usd
CY2022Q2 us-gaap Revenues
Revenues
301109000 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
178916000 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
207684000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40514000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35203000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25306000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17403000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5658000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4545000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7246000 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q2 hsii Reimbursed Expenses
ReimbursedExpenses
2552000 usd
CY2022Q2 hsii Reimbursed Expenses
ReimbursedExpenses
2408000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
260192000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
267243000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13585000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
33866000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1913000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
299000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1377000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
774000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3290000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1073000 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
16875000 usd
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
34939000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7893000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-75000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7524000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
368000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8606000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19726000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20637000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20314000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
410646000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15586000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
443000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1853000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-4141000 usd
CY2023Q1 hsii Stock Issued During Period Value Clawback
StockIssuedDuringPeriodValueClawback
163000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q1 us-gaap Dividends Cash
DividendsCash
3006000 usd
CY2023Q1 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
106000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
421112000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8982000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-75000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1919000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
904000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
405000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q2 us-gaap Dividends Cash
DividendsCash
3003000 usd
CY2023Q2 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
119000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
428317000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
336020000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18467000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1082000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3698000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3219000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q1 us-gaap Dividends Cash
DividendsCash
2940000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
350765000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7524000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3784000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
404000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q2 us-gaap Dividends Cash
DividendsCash
2957000 usd
CY2022Q2 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
147000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
368474000 usd
us-gaap Net Income Loss
NetIncomeLoss
24568000 usd
us-gaap Net Income Loss
NetIncomeLoss
42616000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8692000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5241000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6446000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-246000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3772000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7482000 usd
us-gaap Accretion Expense
AccretionExpense
642000 usd
us-gaap Accretion Expense
AccretionExpense
545000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
1694000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-131000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-309000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
7246000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
59990000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
84783000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2914000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3944000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-273811000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-124281000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
543000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1527000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-2588000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-8114000 usd
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
6403000 usd
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
3297000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2635000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4670000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4902000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
11437000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-290091000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-179512000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
35749000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6814000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4236000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27683000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5358000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
268118000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
990000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
197872000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8604000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
904000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
6234000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
6223000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4141000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3219000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
35946000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47225000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9442000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1772000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11051000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137672000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-208609000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355489000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
545259000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217817000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336650000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217776000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
336634000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
355447000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
545225000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217817000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336650000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355489000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
545259000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8982000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
24149000 usd
us-gaap Net Income Loss
NetIncomeLoss
24568000 usd
us-gaap Net Income Loss
NetIncomeLoss
42616000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20010000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19726000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19958000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19675000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20637000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20314000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20701000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20485000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.08
us-gaap Number Of Reporting Units
NumberOfReportingUnits
5 reporting_unit
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
six months
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
18387000 usd
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
13940000 usd
hsii Increase Decrease In Unbilled Contracts Receivable
IncreaseDecreaseInUnbilledContractsReceivable
4447000 usd
CY2023Q2 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
18194000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
21348000 usd
hsii Increase Decrease In Contract With Customer After Allowance For Credit Loss
IncreaseDecreaseInContractWithCustomerAfterAllowanceForCreditLoss
-3154000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
36581000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
35288000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1293000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44102000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43057000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1045000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
34200000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
14400000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6643000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3703000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4567000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4485000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
9092000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
8843000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3071000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1472000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4987000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2633000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
7638000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
5957000 usd
us-gaap Lease Cost
LeaseCost
14079000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3373000 usd
hsii Allowance For Doubtful Accounts Foreign Currency Translation
AllowanceForDoubtfulAccountsForeignCurrencyTranslation
6000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6979000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
1 investment
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91560000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
85236000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58230000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55029000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33330000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30207000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
2200000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
1800000 usd
us-gaap Depreciation
Depreciation
4200000 usd
us-gaap Depreciation
Depreciation
3600000 usd
us-gaap Lease Cost
LeaseCost
11476000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
10082000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9590000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7520000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3318000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0379
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0327
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9267000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
21021000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12749000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11186000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9818000 usd
CY2023Q2 hsii Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
27566000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
91607000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10060000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
81547000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
84324000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
84337000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217776000 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
21240000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
312121000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
15000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
56000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
312080000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
355447000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
266169000 usd
CY2023Q2 hsii Aggregate Cost Basis For Non Qualified Deferred Compensation Plan
AggregateCostBasisForNonQualifiedDeferredCompensationPlan
35500000 usd
CY2022Q4 hsii Aggregate Cost Basis For Non Qualified Deferred Compensation Plan
AggregateCostBasisForNonQualifiedDeferredCompensationPlan
29100000 usd
CY2023Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
241602000 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
32987000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41157000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14254000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26903000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
138361000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
66588000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7246000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
936000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
198639000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
205885000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
138361000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
7246000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023Q2 us-gaap Goodwill
Goodwill
198639000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
138361000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2022Q4 us-gaap Goodwill
Goodwill
138361000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7246000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
936000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
205885000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
7246000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
198639000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26903000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6333000 usd
CY2023Q2 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y3M18D
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16236000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9903000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6333000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5172000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8223000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6427000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2548000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1523000 usd
CY2023Q2 hsii Hs Finite Lived Intangible Asset Expected Amortization After Year Four
HSFiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
3010000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26903000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
36581000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
35288000 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
14041000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
5434000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
50622000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40722000 usd
CY2023Q2 hsii Acquisition Earnout Accruals Current
AcquisitionEarnoutAccrualsCurrent
0 usd
CY2022Q4 hsii Acquisition Earnout Accruals Current
AcquisitionEarnoutAccrualsCurrent
36010000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
36017000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
20006000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36017000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
56016000 usd
CY2023Q2 hsii Acquisition Earnout Accruals Non Current
AcquisitionEarnoutAccrualsNonCurrent
37278000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
4727000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42005000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1060000 shares
CY2023Q2 hsii Share Based Compensation Arrangement By Share Based Payment Award Shares Issued To Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedToDate
4158627 shares
CY2023Q2 hsii Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Forfeited To Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedToDate
771055 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1022428 shares
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
445000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-2100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-2800000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-2800000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
16134 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
11850 shares
CY2008Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
36000 shares
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
900000 usd
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q2 hsii Treasury Stock Shares Acquired To Date
TreasuryStockSharesAcquiredToDate
1074670 shares
CY2023Q2 hsii Treasury Stock Value Acquired To Date
TreasuryStockValueAcquiredToDate
29200000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
20800000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
3400000 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
16900000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 usd
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
34900000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10800000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.468
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.309
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
39700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15100000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
62800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20200000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.381
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.322
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
368000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 operatingsegment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271225000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
298701000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
510542000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
582562000 usd
CY2023Q2 hsii Reimbursement Revenue
ReimbursementRevenue
2552000 usd
CY2022Q2 hsii Reimbursement Revenue
ReimbursementRevenue
2408000 usd
hsii Reimbursement Revenue
ReimbursementRevenue
5354000 usd
hsii Reimbursement Revenue
ReimbursementRevenue
4084000 usd
CY2023Q2 us-gaap Revenues
Revenues
273777000 usd
CY2022Q2 us-gaap Revenues
Revenues
301109000 usd
us-gaap Revenues
Revenues
515896000 usd
us-gaap Revenues
Revenues
586646000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5658000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4545000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11186000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8947000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13585000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
33866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
31356000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
64098000 usd
CY2023Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
4400000 usd

Files In Submission

Name View Source Status
0001066605-23-000068-index-headers.html Edgar Link pending
0001066605-23-000068-index.html Edgar Link pending
0001066605-23-000068.txt Edgar Link pending
0001066605-23-000068-xbrl.zip Edgar Link pending
ex101-hsiix20230630.htm Edgar Link pending
ex102-hsiix20230630.htm Edgar Link pending
ex103-hsiix20230630.htm Edgar Link pending
ex311-hsiix20230630.htm Edgar Link pending
ex312-hsiix20230630.htm Edgar Link pending
ex321-hsiix20230630.htm Edgar Link pending
ex322-hsiix20230630.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hsii-20230630.htm Edgar Link pending
hsii-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hsii-20230630_def.xml Edgar Link unprocessable
hsii-20230630_cal.xml Edgar Link unprocessable
hsii-20230630_pre.xml Edgar Link unprocessable
hsii-20230630_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hsii-20230630_lab.xml Edgar Link unprocessable